CD21 IS A LIGAND FOR CD23 AND REGULATES IGE PRODUCTION

被引:458
作者
AUBRY, JP [1 ]
POCHON, S [1 ]
GRABER, P [1 ]
JANSEN, KU [1 ]
BONNEFOY, JY [1 ]
机构
[1] GLAXO INST MOLEC BIOL,14 CHEMIN AULX,CH-1228 PLAN LES OUATES,SWITZERLAND
关键词
D O I
10.1038/358505a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 [理学]; 0710 [生物学]; 09 [农学];
摘要
THE molecule CD23, a low-affinity receptor for IgE (Fc-epsilon-R2)1,2, is a type II transmembrane molecule expressed on many haemopoietic cell types3,4. CD23 has pleiotropic roles in the control of lymphocyte behaviour5-9, suggesting that CD23 may interact with another ligand in addition to IgE. To identify such a CD23 ligand, we expressed and purified full-length recombinant CD23, incorporated it into fluorescent liposomes and used these as a probe. We report here that fluorescent liposomes carrying CD23 interact specifically with the cell-surface protein CD21, identified as the receptor for Epstein-Barr virus and the complement receptor-2 on B cells, some T cells and follicular dendritic cells. In addition, fluorescent CD23-liposomes were shown to bind to hamster kidney cells (BHK-21) transfected with CD21 complementary DNA. The interaction between fluorescent CD23-liposomes and B cells or CD21-transfected BHK-21 cells was specifically inhibited by anti-CD21 and anti-CD23 monoclonal antibodies. Western blotting analysis revealed that C-14-labelled liposomes carrying CD23, in contrast to anti-CD21 antibodies, reacted with a subtype of CD21 molecules. Triggering of CD21 either with an anti-CD21 antibody or with recombinant soluble CD23 was shown to increase specifically interleukin-4-induced IgE production from blood mononuclear cells. These results demonstrate that the cell-surface protein CD21 is a ligand for CD23 and that the pairing of these molecules may participate in the control of IgE production.
引用
收藏
页码:505 / 507
页数:3
相关论文
共 37 条
[1]
EPSTEIN-BARR VIRUS (EBV)-CONTAINING NASOPHARYNGEAL CARCINOMA-CELLS EXPRESS THE B-CELL ACTIVATION ANTIGEN BLAST2 CD23 AND LOW-LEVELS OF THE EBV RECEPTOR CR-2 [J].
BILLAUD, M ;
BUSSON, P ;
HUANG, D ;
MUELLERLANTZCH, N ;
ROUSSELET, G ;
PAVLISH, O ;
WAKASUGI, H ;
SEIGNEURIN, JM ;
TURSZ, T ;
LENOIR, GM .
JOURNAL OF VIROLOGY, 1989, 63 (10) :4121-4128
[2]
BONNEFOY JY, 1987, J IMMUNOL, V138, P2970
[3]
THE LOW-AFFINITY RECEPTOR FOR IGE (CD23) ON LYMPHOCYTES-B IS SPATIALLY ASSOCIATED WITH HLA-DR ANTIGENS [J].
BONNEFOY, JY ;
GUILLOT, O ;
SPITS, H ;
BLANCHARD, D ;
ISHIZAKA, K ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (01) :57-72
[4]
INHIBITION OF HUMAN INTERLEUKIN-4-INDUCED IGE SYNTHESIS BY A SUBSET OF ANTI-CD23/FC-EPSILON-RII MONOCLONAL-ANTIBODIES [J].
BONNEFOY, JY ;
SHIELDS, J ;
MERMOD, JJ .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (01) :139-144
[5]
CAIRNS J, 1990, EUR J IMMUNOL, V20, P534
[6]
STABLE EXPRESSION AND FUNCTION OF EBV/C3D RECEPTOR FOLLOWING GENOMIC TRANSFECTION INTO MURINE FIBROBLAST L-CELLS [J].
CANTALOUBE, JF ;
PIECHACZYK, M ;
CALENDER, A ;
LENOIR, G ;
MINTY, A ;
CARRIERE, D ;
FISCHER, E ;
PONCELET, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (02) :409-416
[7]
EPSTEIN-BARR-VIRUS COMPLEMENT C3D RECEPTOR IS AN INTERFERON-ALPHA RECEPTOR [J].
DELCAYRE, AX ;
SALAS, F ;
MATHUR, S ;
KOVATS, K ;
LOTZ, M ;
LERNHARDT, W .
EMBO JOURNAL, 1991, 10 (04) :919-926
[8]
HUMAN IGE-BINDING FACTORS [J].
DELESPESSE, G ;
SARFATI, M ;
HOFSTETTER, H .
IMMUNOLOGY TODAY, 1989, 10 (05) :159-164
[9]
DORKEN B, 1989, LEUCOCYTE TYPING, V4, P99
[10]
FISCHER E, 1991, J IMMUNOL, V146, P865